Caspases playing in the field of neuroinflammation: Old and new players

Developmental Neuroscience

Volumn 35, Issue 2-3, 2013, Pages 88-101

  Venero, Jose L ^a   Burguillos, Miguel A ^b   Joseph, Bertrand ^b  

^a UNIVERSITY OF SEVILLE   (Spain)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Apoptosis; Caspase 1; Caspase 3; Caspase 8; Cytokines; Inflammasome; Inflammation; Microglia

Indexed keywords

CASPASE; CASPASE 11; CASPASE 12; CASPASE 14; CASPASE 3; CASPASE 4; CASPASE 8; CYTOKINE; EFFECTOR CASPASE; INFLAMMASOME; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 33; TOLL LIKE RECEPTOR;

APOPTOSIS; B LYMPHOCYTE; CELL DIFFERENTIATION; CONFERENCE PAPER; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVE SITE; ENZYME SPECIFICITY; GLIA CELL; HUMAN; MACROPHAGE; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE; TRANSCRIPTION INITIATION;

EID: 84880193975     PISSN: 03785866     EISSN: 14219859     Source Type: Journal    
DOI: 10.1159/000346155     Document Type: Conference Paper

References (130)

1. Black RA, Kronheim SR, Merriam JE, March CJ, Hopp TP: A pre-aspartate-specific protease from human leukocytes that cleaves prointerleukin-1 beta. J Biol Chem 1989; 264: 5323-5326.
2. Kostura MJ, Tocci MJ, Limjuco G, Chin J, Cameron P, Hillman AG, Chartrain NA, Schmidt JA: Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc Natl Acad Sci USA 1989; 86: 5227-5231.
3. Cerretti DP, Kozlosky CJ, Mosley B, Nelson N, Van Ness K, Greenstreet TA, March CJ, Kronheim SR, Druck T, Cannizzaro LA, et al: Molecular cloning of the interleukin-1 beta converting enzyme. Science 1992; 256: 97-100.
4. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, et al: A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992; 356: 768-774.
5. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR: The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-
6. beta-converting enzyme. Cell 1993; 75: 641-652.
7. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J: Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 1993; 75: 653-660.
8. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, et al: Identification and inhibition of the ICE/ CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376: 37-43.
9. Schlegel J, Peters I, Orrenius S, Miller DK, Thornberry NA, Yamin TT, Nicholson DW: CPP32/apopain is a key interleukin 1 beta converting enzyme-like protease involved in fas-mediated apoptosis. J Biol Chem 1996; 271: 1841-1844.
10. Thornberry NA, Lazebnik Y: Caspases: Enemies within. Science 1998; 281: 1312-1316.
11. Samali A, Zhivotovsky B, Jones D, Nagata S, Orrenius S: Apoptosis: cell death defined by caspase activation. Cell Death Differ 1999; 6: 495-496.
12. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J: Human ICE/CED-3 protease nomenclature. Cell 1996; 87: 171.
13. Martinon F, Tschopp J: Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004; 117: 561-574.
14. Saleh M, Vaillancourt JP, Graham RK, Huyck M, Srinivasula SM, Alnemri ES, Steinberg MH, Nolan V, Baldwin CT, Hotchkiss RS, Buchman TG, Zehnbauer BA, Hayden MR, Farrer LA, Roy S, Nicholson DW: Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 2004; 429: 75-79.
15. Fernandes-Alnemri T, Armstrong RC, Krebs J, Srinivasula SM, Wang L, Bullrich F, Fritz LC, Trapani JA, Tomaselli KJ, Litwack G, Alnemri ES: In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci USA 1996; 93: 7464-7469.
16. Reed JC, Doctor K, Rojas A, Zapata JM, Stehlik C, Fiorentino L, Damiano J, Roth W, Matsuzawa S, Newman R, Takayama S, Marusawa H, Xu F, Salvesen G, Godzik A: Comparative analysis of apoptosis and inflammation genes of mice and humans. Genome Res 2003; 13: 1376-1388.
17. Koenig U, Eckhart L, Tschachler E: Evidence that caspase-13 is not a human but a bovine gene. Biochem Biophys Res Commun 2001; 285: 1150-1154.
18. Fuentes-Prior P, Salvesen GS: The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem J 2004; 384: 201-232.
19. Park HH, Lo YC, Lin SC, Wang L, Yang JK, Wu H: The death domain superfamily in intracellular signaling of apoptosis and inflammation. Annu Rev Immunol 2007; 25: 561-586.
20. Ramage P, Cheneval D, Chvei M, Graff P, Hemmig R, Heng R, Kocher HP, Mackenzie A, Memmert K, Revesz L, et al: Expression, refolding, and autocatalytic proteolytic processing of the interleukin-1 beta-converting enzyme precursor. J Biol Chem 1995; 270: 9378-9383.
21. Stennicke HR, Salvesen GS: Catalytic properties of the caspases. Cell Death Differ 1999; 6: 1054-1059.
22. Luthi AU, Martin SJ: The CASBAH: A searchable database of caspase substrates. Cell Death Differ 2007; 14: 641-650.
23. Crawford ED, Wells JA: Caspase substrates and cellular remodeling. Annu Rev Biochem 2011; 80: 1055-1087.
24. Timmer JC, Salvesen GS: Caspase substrates. Cell Death Differ 2007; 14: 66-72.
25. Wong WW: ICE family proteases in inflammation and apoptosis. Agents Actions Suppl 1998; 49: 5-13.
26. Miller DK, Myerson J, Becker JW: The interleukin-
27. beta converting enzyme family of cysteine proteases. J Cell Biochem 1997; 64: 2-10.
28. Lamkanfi M, Declercq W, Kalai M, Saelens X, Vandenabeele P: Alice in caspase land. A phylogenetic analysis of caspases from worm to man. Cell Death Differ 2002; 9: 358-361.
29. Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillancourt JP, Chapman KT, Nicholson DW: A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 1997; 272: 17907-17911.
30. Lavrik IN, Golks A, Krammer PH: Caspases: pharmacological manipulation of cell death. J Clin Invest 2005; 115: 2665-2672.
31. Pop C, Salvesen GS: Human caspases: Activation, specificity, and regulation. J Biol Chem 2009; 284: 21777-21781.
32. Lippens S, Kockx M, Knaapen M, Mortier L, Polakowska R, Verheyen A, Garmyn M, Zwijsen A, Formstecher P, Huylebroeck D, Vandenabeele P, Declercq W: Epidermal differentiation does not involve the pro-apoptotic executioner caspases, but is associated with caspase-14 induction and processing. Cell Death Differ 2000; 7: 1218-1224.
33. Riedl SJ, Shi Y: Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 2004; 5: 897-907.
34. Mace PD, Riedl SJ: Molecular cell death platforms and assemblies. Curr Opin Cell Biol 2010; 22: 828-836.
35. Zimmermann KC, Bonzon C, Green DR: The machinery of programmed cell death. Pharmacol Ther 2001; 92: 57-70.
36. Martinon F, Tschopp J: Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 2007; 14: 10-22.
37. Schroder K, Tschopp J: The inflammasomes. Cell 2010; 140: 821-832.
38. van de Veerdonk FL, Netea MG, Dinarello CA, Joosten LA: Inflammasome activation and IL-1beta and IL-18 processing during infection. Trends Immunol 2011; 32: 110-116.
39. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J: Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 2000; 403: 98-103.
40. Obeng EA, Boise LH: Caspase-12 and caspase-
41. are not required for caspase-dependent endoplasmic reticulum stress-induced apoptosis. J Biol Chem 2005; 280: 29578-29587.
42. Saleh M, Mathison JC, Wolinski MK, Bensinger SJ, Fitzgerald P, Droin N, Ulevitch RJ, Green DR, Nicholson DW: Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice. Nature 2006; 440: 1064-1068.
43. Hyman BT, Yuan J: Apoptotic and non-apoptotic roles of caspases in neuronal physiology and pathophysiology. Nat Rev Neurosci 2012; 13: 395-406.
44. Venero JL, Burguillos MA, Brundin P, Joseph B: The executioners sing a new song: killer caspases activate microglia. Cell Death Differ 2011; 18: 1679-1691.
45. Labbe K, Saleh M: Cell death in the host response to infection. Cell Death Differ 2008; 15: 1339-1349.
46. Hagberg H, Gressens P, Mallard C: Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adults. Ann Neurol 2012; 71: 444-457.
47. Frank-Cannon TC, Alto LT, McAlpine FE, Tansey MG: Does neuroinflammation fan the flame in neurodegenerative diseases? Mol Neurodegener 2009; 4: 47.
48. Akira S, Uematsu S, Takeuchi O: Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
49. Beg AA: Endogenous ligands of toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol 2002; 23: 509-512.
50. Akira S, Takeda K: Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511.
51. Kawai T, Akira S: TLR signaling. Cell Death Differ 2006; 13: 816-825.
52. Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol 2003; 21: 335-376.
53. Bsibsi M, Ravid R, Gveric D, van Noort JM: Broad expression of toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 2002; 61: 1013-1021.
54. Lee SJ, Lee S: Toll-like receptors and inflammation in the cns. Curr Drug Targets Inflamm Allergy 2002; 1: 181-191.
55. Strober W, Murray PJ, Kitani A, Watanabe T: Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol 2006; 6: 9-20.
56. Yazdi AS, Drexler SK, Tschopp J: The role of the inflammasome in nonmyeloid cells. J Clin Immunol 2010; 30: 623-627.
57. Trendelenburg G: Acute neurodegeneration and the inflammasome: central processor for danger signals and the inflammatory response J Cereb Blood Flow Metab 2008; 28: 867-881.
58. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ, Golenbock DT: The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nature immunology 2008; 9: 857-865.
59. Salminen A, Ojala J, Suuronen T, Kaarniranta K, Kauppinen A: Amyloid-beta oligomers set fire to inflammasomes and induce Alzheimer's pathology. J Cell Mol Med 2008; 12: 2255-2262.
60. Fantuzzi G, Puren AJ, Harding MW, Livingston DJ, Dinarello CA: Interleukin-18 regulation of interferon gamma production and cell proliferation as shown in interleukin-1betaconverting enzyme (caspase-1)-deficient mice. Blood 1998; 91: 2118-2125.
61. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, Quintal L, Sekut L, Talanian R, Paskind M, Wong W, Kamen R, Tracey D, Allen H: Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 1997; 386: 619-623.
62. Kumar S, Hanning CR, Brigham-Burke MR, Rieman DJ, Lehr R, Khandekar S, Kirkpatrick RB, Scott GF, Lee JC, Lynch FJ, Gao W, Gambotto A, Lotze MT: Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production. Cytokine 2002; 18: 61-71.
63. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA: IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23: 479-490.
64. Cayrol C, Girard JP: The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci USA 2009; 106: 9021-9026.
65. Sharma S, Kulk N, Nold MF, Graf R, Kim SH, Reinhardt D, Dinarello CA, Bufler P: The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines. J Immunol 2008; 180: 5477-5482.
66. Kayagaki N, Warming S, Lamkanfi M, Vande Walle L, Louie S, Dong J, Newton K, Qu Y, Liu J, Heldens S, Zhang J, Lee WP, Roose-Girma M, Dixit VM: Non-canonical inflammasome activation targets caspase-11. Nature 2011; 479: 117-121.
67. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C, McDowell J, Paskind M, Rodman L, Salfeld J, et al: Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 1995; 80: 401-411.
68. Wang S, Miura M, Jung YK, Zhu H, Li E, Yuan J: Murine caspase-11, an ice-interacting protease, is essential for the activation of ice. Cell 1998; 92: 501-509.
69. Rathinam VA, Vanaja SK, Waggoner L, Sokolovska A, Becker C, Stuart LM, Leong JM, Fitzgerald KA: TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria. Cell 2012; 150: 606-619.
70. Hisahara S, Yuan J, Momoi T, Okano H, Miura M: Caspase-11 mediates oligodendrocyte cell death and pathogenesis of autoimmunemediated demyelination. Journal Exp Med 2001; 193: 111-122.
71. Lin XY, Choi MS, Porter AG: Expression analysis of the human caspase-1 subfamily reveals specific regulation of the CASP5 gene by lipopolysaccharide and interferon-gamma. J Biol Chem 2000; 275: 39920-39926.
72. Bian ZM, Elner SG, Elner VM: Dual involvement of caspase-4 in inflammatory and ER stress-induced apoptotic responses in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2009; 50: 6006-6014.
73. Nadiri A, Wolinski MK, Saleh M: The inflammatory caspases: key players in the host response to pathogenic invasion and sepsis. J Immunol 2006; 177: 4239-4245.
74. Sollberger G, Strittmatter GE, Kistowska M, French LE, Beer HD: Caspase-4 is required for activation of inflammasomes. J Immunol 2012; 188: 1992-2000.
75. Martinon F, Burns K, Tschopp J: The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002; 10: 417-426.
76. Gorman AM, Healy SJ, Jager R, Samali A: Stress management at the ER: regulators of ER stress-induced apoptosis. Pharmacol Ther 2012; 134: 306-316.
77. Hitomi J, Katayama T, Eguchi Y, Kudo T, Taniguchi M, Koyama Y, Manabe T, Yamagishi S, Bando Y, Imaizumi K, Tsujimoto Y, Tohyama M: Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and abeta-induced cell death. J Cell Biol 2004; 165: 347-356.
78. Quiroz-Baez R, Ferrera P, Rosendo-Gutierrez R, Moran J, Bermudez-Rattoni F, Arias C: Caspase-12 activation is involved in amyloidbeta protein-induced synaptic toxicity. J Alzheimers Dis 2011; 26: 467-476.
79. Wootz H, Hansson I, Korhonen L, Napankangas U, Lindholm D: Caspase-12 cleavage and increased oxidative stress during motoneuron degeneration in transgenic mouse model of als. Biochem Biophys Res Commun 2004; 322: 281-286.
80. Vijayalakshmi K, Alladi PA, Ghosh S, Prasanna VK, Sagar BC, Nalini A, Sathyaprabha TN, Raju TR: Evidence of endoplasmic reticular stress in the spinal motor neurons exposed to CSF from sporadic amyotrophic lateral sclerosis patients. Neurobiol Dis 2011; 41: 695-705.
81. Hetz C, Russelakis-Carneiro M, Maundrell K, Castilla J, Soto C: Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J 2003; 22: 5435-5445.
82. Hetz C, Russelakis-Carneiro M, Walchli S, Carboni S, Vial-Knecht E, Maundrell K, Castilla J, Soto C: The disulfide isomerase GRP58 is a protective factor against prion neurotoxicity. J Neurosci 2005; 25: 2793-2802.
83. Di Sano F, Ferraro E, Tufi R, Achsel T, Piacentini M, Cecconi F: Endoplasmic reticulum stress induces apoptosis by an apoptosomedependent but caspase 12-independent mechanism. J Biol Chem 2006; 281: 2693-2700.
84. Fernando P, Megeney LA: Is caspase-dependent apoptosis only cell differentiation taken to the extreme? FASEB J 2007; 21: 8-17.
85. Zermati Y, Garrido C, Amsellem S, Fishelson S, Bouscary D, Valensi F, Varet B, Solary E, Hermine O: Caspase activation is required for terminal erythroid differentiation. Journal Exp Med 2001; 193: 247-254.
86. Weil M, Raff MC, Braga VM: Caspase activation in the terminal differentiation of human epidermal keratinocytes. Curr Biol 1999; 9: 361-364.
87. Okuyama R, Nguyen BC, Talora C, Ogawa E, Tommasi di Vignano A, Lioumi M, Chiorino G, Tagami H, Woo M, Dotto GP: High commitment of embryonic keratinocytes to terminal differentiation through a notch1-caspase
88. regulatory mechanism. Dev Cell 2004; 6: 551-562.
89. Zandy AJ, Lakhani S, Zheng T, Flavell RA, Bassnett S: Role of the executioner caspases during lens development. J Biol Chem 2005; 280: 30263-30272.
90. Miossec C, Dutilleul V, Fassy F, Diu-Hercend A: Evidence for CPP32 activation in the absence of apoptosis during T lymphocyte stimulation. J Biol Chem 1997; 272: 13459-13462.
91. Kennedy NJ, Kataoka T, Tschopp J, Budd RC: Caspase activation is required for T cell proliferation. J Exp Med 1999; 190: 1891-1896.
92. Boissonnas A, Bonduelle O, Lucas B, Debre P, Autran B, Combadiere B: Differential requirement of caspases during naive T cell proliferation. Eur J Immunol 2002; 32: 3007-3015.
93. Chun HJ, Zheng L, Ahmad M, Wang J, Speirs CK, Siegel RM, Dale JK, Puck J, Davis J, Hall CG, Skoda-Smith S, Atkinson TP, Straus SE, Lenardo MJ: Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 2002; 419: 395-399.
94. Sordet O, Rebe C, Plenchette S, Zermati Y, Hermine O, Vainchenker W, Garrido C, Solary E, Dubrez-Daloz L: Specific involvement of caspases in the differentiation of monocytes into macrophages. Blood 2002; 100: 4446-4453.
95. Rebe C, Cathelin S, Launay S, Filomenko R, Prevotat L, L'Ollivier C, Gyan E, Micheau O, Grant S, Dubart-Kupperschmitt A, Fontenay M, Solary E: Caspase-8 prevents sustained activation of NF-kappaB in monocytes undergoing macrophagic differentiation. Blood 2007; 109: 1442-1450.
96. Jacquel A, Benikhlef N, Paggetti J, Lalaoui N, Guery L, Dufour EK, Ciudad M, Racoeur C, Micheau O, Delva L, Droin N, Solary E: Colony-stimulating factor-1-induced oscillations in phosphatidylinositol-3 kinase/AKT are required for caspase activation in monocytes undergoing differentiation into macrophages. Blood 2009; 114: 3633-3641.
97. Kang TB, Ben-Moshe T, Varfolomeev EE, Pewzner-Jung Y, Yogev N, Jurewicz A, Waisman A, Brenner O, Haffner R, Gustafsson E, Ramakrishnan P, Lapidot T, Wallach D: Caspase-8 serves both apoptotic and nonapoptotic roles. J Immunol 2004; 173: 2976-2984.
98. Alliot F, Godin I, Pessac B: Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Res Dev Brain Res 1999; 117: 145-152.
99. Gomes-Leal W: Microglial physiopathology: how to explain the dual role of microglia after acute neural disorders? Brain Behav 2012; 2: 345-356.
100. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, Samokhvalov IM, Merad M: Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010; 330: 841-845.
101. Burguillos MA, Deierborg T, Kavanagh E, Persson A, Hajji N, Garcia-Quintanilla A, Cano J, Brundin P, Englund E, Venero JL, Joseph B: Caspase signalling controls microglia activation and neurotoxicity. Nature 2011; 472: 319-324.
102. Castano A, Herrera AJ, Cano J, Machado A: Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system. J Neurochem 1998; 70: 1584-1592.
103. Herrera AJ, Castano A, Venero JL, Cano J, Machado A: The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system. Neurobiol Dis 2000; 7: 429-447.
104. Brown GC, Neher JJ: Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol Neurobiol 2010; 41: 242-247.
105. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH: Mechanisms underlying inflammation in neurodegeneration. Cell 2010; 140: 918-934.
106. Chauvier D, Renolleau S, Holifanjaniaina S, Ankri S, Bezault M, Schwendimann L, Rousset C, Casimir R, Hoebeke J, Smirnova M, Debret G, Trichet AP, Carlsson Y, Wang X, Bernard E, Hebert M, Rauzier JM, Matecki S, Lacampagne A, Rustin P, Mariani J, Hagberg H, Gressens P, Charriaut-Marlangue C, Jacotot E: Targeting neonatal ischemic brain injury with a pentapeptide-based irreversible caspase inhibitor. Cell Death Dis 2011; 2:e203.
107. Al-Jamal KT, Gherardini L, Bardi G, Nunes A, Guo C, Bussy C, Herrero MA, Bianco A, Prato M, Kostarelos K, Pizzorusso T: Functional motor recovery from brain ischemic insult by carbon nanotube-mediated siRNA silencing. Proc Natl Acad Sci USA 2011; 108: 10952-10957.
108. Nunes A, Bussy C, Gherardini L, Meneghetti M, Herrero MA, Bianco A, Prato M, Pizzorusso T, Al-Jamal KT, Kostarelos K: In vivo degradation of functionalized carbon nanotubes after stereotactic administration in the brain cortex. Nanomedicine (Lond) 2012; 7: 1485-1494.
109. Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL, Rebrikov D, Brodianski VM, Kemper OC, Kollet O, Lapidot T, Soffer D, Sobe T, Avraham KB, Goncharov T, Holtmann H, Lonai P, Wallach D: Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 1998; 9: 267-276.
110. Zhang J, Cado D, Chen A, Kabra NH, Winoto A: Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 1998; 392: 296-300.
111. Yeh WC, Pompa JL, McCurrach ME, Shu HB, Elia AJ, Shahinian A, Ng M, Wakeham A, Khoo W, Mitchell K, El-Deiry WS, Lowe SW, Goeddel DV, Mak TW: FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 1998; 279: 1954-1958.
112. Yeh WC, Itie A, Elia AJ, Ng M, Shu HB, Wakeham A, Mirtsos C, Suzuki N, Bonnard M, Goeddel DV, Mak TW: Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 2000; 12: 633-642.
113. Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B, Tschopp J: Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase rip as effector molecule. Nat Immunol 2000; 1: 489-495.
114. Lin Y, Choksi S, Shen HM, Yang QF, Hur GM, Kim YS, Tran JH, Nedospasov SA, Liu ZG: Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation. J Biol Chem 2004; 279: 10822-10828.
115. Vercammen D, Brouckaert G, Denecker G, Van de Craen M, Declercq W, Fiers W, Vandenabeele P: Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J Exp Med 1998; 188: 919-930.
116. Lee EW, Seo J, Jeong M, Lee S, Song J: The roles of FADD in extrinsic apoptosis and necroptosis. BMB Rep 2012; 45: 496-508.
117. Feoktistova M, Geserick P, Panayotova-Dimitrova D, Leverkus M: Pick your poison: the ripoptosome, a cell death platform regulating apoptosis and necroptosis. Cell Cycle 2012; 11: 460-467.
118. Moquin D, Chan FK: The molecular regulation of programmed necrotic cell injury. Trends Biochem Sci 2010; 35: 434-441.
119. Oberst A, Dillon CP, Weinlich R, McCormick LL, Fitzgerald P, Pop C, Hakem R, Salvesen GS, Green DR: Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 2011; 471: 363-367.
120. Kaiser WJ, Upton JW, Long AB, Livingston-Rosanoff D, Daley-Bauer LP, Hakem R, Caspary T, Mocarski ES: RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 2011; 471: 368-372.
121. Ozturk S, Schleich K, Lavrik IN: Cellular FLICE-like inhibitory proteins (c-FLIPs): fine-tuners of life and death decisions. Exp Cell Res 2012; 318: 1324-1331.
122. Su H, Bidere N, Zheng L, Cubre A, Sakai K, Dale J, Salmena L, Hakem R, Straus S, Lenardo M: Requirement for caspase-8 in NFkappaB activation by antigen receptor. Science 2005; 307: 1465-1468.
123. Imtiyaz HZ, Rosenberg S, Zhang Y, Rahman ZS, Hou YJ, Manser T, Zhang J: The Fas-associated death domain protein is required in apoptosis and TLR-induced proliferative responses in B cells. J Immunol 2006; 176: 6852-6861.
124. Oberst A, Green DR: It cuts both ways: reconciling the dual roles of caspase 8 in cell death and survival. Nat Rev Mol Cell Biol 2011; 12: 757-763.
125. Perry VH: Contribution of systemic inflammation to chronic neurodegeneration. Acta Neuropathol 2010; 120: 277-286.
126. Simard AR, Soulet D, Gowing G, Julien JP, Rivest S: Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 2006; 49: 489-502.
127. Stalder AK, Ermini F, Bondolfi L, Krenger W, Burbach GJ, Deller T, Coomaraswamy J, Staufenbiel M, Landmann R, Jucker M: Invasion of hematopoietic cells into the brain of amyloid precursor protein transgenic mice. J Neurosci 2005; 25: 11125-11132.
128. Czeh M, Gressens P, Kaindl AM: The yin and yang of microglia. Dev Neurosci 2011; 33: 199-209.
129. Lalancette-Hebert M, Gowing G, Simard A, Weng YC, Kriz J: Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 2007; 27: 2596-2605.
130. Gribble GW: Fluoroacetate toxicity. J Chem Educ 1973; 50: 460-462.